Table 3.

Expression of NF-κB (p65), COX-2, and pSTAT3 in PBMC derived from patients with pancreatic cancer by immunohistochemical staining

Patient no.NF-κB (p65)*NF-κB (p65)COX-2*COX-2pSTAT3*pSTAT3
366845236125
471598441368
5737042
7866373575648
858766838279
10655243
12647830
13785261485821
14697432
15835921
16788256795232
17836153244714
18866648
20877448285318
21623869322225
22766944643931
23485617
24675836
25596448
  • NOTE: Mean ± SD for p65, COX-2, and pSTAT3 pretreatment and posttreatment are 74.50 ± 10.00 and 65.80 ± 14.20 (P = 0.131), 60.80 ± 12.53 and 44.7 ± 17.37 (P = 0.029), and 40.20 ± 15.76 and 21.10 ± 13.30 (P = 0.009), respectively.

  • * Percentage of positive cells before treatment (by immunohistochemistry; an average of 300 cells was counted to make this determination).

  • Percentage of positive cells after treatment (by immunohistochemistry; an average of 300 cells was counted to make this determination).